Shopping Cart
- Remove All
- Your shopping cart is currently empty
W4275 (Compound 42) is a selecTive NSD2 inhibiTor wiTh oral acTiviTy and an IC50 of 17 nM. IT exhibiTs anTiproliferaTive acTiviTy, wiTh an IC50 of 230 nM againsT RS411 cells, and significanTly inhibiTs Tumor growTh in an RS411 Tumor xenografT model. PharmacokineTic analysis in mice shows ThaT W4275 has a favorable oral bioavailabiliTy (F is 27.34%). W4275 holds poTenTial for use in cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | W4275 (Compound 42) is a selecTive NSD2 inhibiTor wiTh oral acTiviTy and an IC50 of 17 nM. IT exhibiTs anTiproliferaTive acTiviTy, wiTh an IC50 of 230 nM againsT RS411 cells, and significanTly inhibiTs Tumor growTh in an RS411 Tumor xenografT model. PharmacokineTic analysis in mice shows ThaT W4275 has a favorable oral bioavailabiliTy (F is 27.34%). W4275 holds poTenTial for use in cancer research. |
Targets&IC50 | NSD2:17 nM |
Molecular Weight | 468.59 |
Formula | C25H36N6O3 |
Cas No. | 3051650-00-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.